Skip to main content
. 2019 Mar 22;18:93. doi: 10.1186/s12936-019-2724-z

Fig. 27.

Fig. 27

Key stages in the hit to lead pathway of KAF156. Potential metabolic stability issues were addressed through fluorine bioisosteres giving K2. Introduction of a dimethyl group on the piperazine ring resulted in increased potency and led to the optimized compound